By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Aug 1, 2018/News
Issues that directly affect PTs, PTAs, and society as a whole—population health, the opioid crisis, innovative delivery models, and much more—will be front and center at the 2018 APTA State Policy and Payment Forum.
Explore key resources to help physical therapy faculty integrate interprofessional education, or IPE, into their teaching and program design.
Feb 12, 2020/Article
Medicare and Medicaid can play a major role in hospice care. Here are four recommended CMS resources that can help you understand the system.
Oct 21, 2020/APTA Live
Learn how you can take action, and why it matters. With PTA Caucus Delegate, Jodi Pfeiffer, chats with Kara Gainer, APTA director of regulatory affairs, and Justin Elliot, APTA vice president of government affairs.
Sep 5, 2025/News
Congress is beginning to formally investigate ongoing issues with the TRICARE system that have affected health care providers and military families who rely on the program for coverage and care.
Oct 1, 2024/Feature
How physical therapists and physical therapist assistants can incorporate lifestyle medicine tenets into patient care for improved outcomes.
Dec 11, 2020/CPG
This guideline provides recommendations related to the diagnosis and management of peripheral arterial disease (PAD) in people aged 18 and over.
Dec 11, 2025/Policies & Bylaws
BOD Y11-25-04-01: This policy establishes standardized language usage in the development of Association policies, positions, and recommendations to the Board of Directors. It ensures clarity, consistency, and appropriate interpretation of intent and resource implications.
Mar 31, 2015/CPG
The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.
Jul 28, 2015/CPG
Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review and analysis of the evidence.